Overview of Dr. Yamada
I am a board certified gynecologic oncologist and I lead the Section of Gynecologic Oncology at the University of Chicago. I have a keen interest in developing systems to giving the community access to the best gyn oncology care possible. I collaborate with translational and clinical researchers to bring novel therapies to ovarian cancer and endometrial cancer patients. I also have a strong interest in education and administrative leadership. I was a member of the gynecologic oncology board of the American Board of Obstetrics and Gynecology between 2014-2020 and served as President for the Society of Gynecologic Oncology 2021-2022.
Office
5758 S. Maryland Ave.
Chicago, IL 60637- Is this information wrong?
Education & Training
- University of California (Irvine)Fellowship, Gynecologic Oncology, 1997 - 1999
- Cedars-Sinai Medical CenterFellowship, Gynecologic Oncology, 1995 - 1997
- Los Angeles County-Harbor-UCLA Medical CenterResidency, Obstetrics and Gynecology, 1991 - 1995
- David Geffen School of Medicine at UCLAClass of 1991
- Brown UniversityBA, Biology and Classics-Latin, 1982 - 1986
Certifications & Licensure
- IL State Medical License 1999 - 2026
- IN State Medical License 2008 - 2025
- CA State Medical License 1993 - 1999
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Deputy Editor Gynecologic Oncology, 2024
- President Society of Gynecologic Oncology, 2021-2022
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
- Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors Start of enrollment: 2010 Feb 08
- Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Start of enrollment: 2012 Jun 18
- Join now to see all
Publications & Presentations
PubMed
- 13 citationsClinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure.Ana I. Tergas, Rebecca Buell-Gutbrod, Katja Gwin, Masha Kocherginsky, Sarah M. Temkin
Gynecologic Oncology. 2012-11-01 - 46 citationsThe Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasmsClaire Hoppenot, Darryl Schuitevoerder, Francisco J. Izquierdo, Alejandro Plana, Bhavana Pothuri
Cancer. 2020-06-01 - 1532 citationsAdipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growthKristin M Nieman, Hilary A. Kenny, Carla Penicka, Andras Ladanyi, Rebecca Buell-Gutbrod
Nature Medicine. 2011-11-01
Journal Articles
- Case Report Second Primary Rhabdomyosarcoma of the Uterine Cervix Presenting with Synchronous Ovarian Sertoli-Leydig Cell Tumor: An Illustrative Case of DICER1 SyndromeMatthew Cowan, Melody Perpich, Mark A Applebaum, S Diane Yamada, Andrea D Olivas, Ricardo R Lastra, ScienceDirect
Professional Memberships
- Fellow
- Member
- Society of Gynecologic OncologyMember
- Member
Hospital Affiliations
- University of Chicago Medical CenterChicago, Illinois
- Northwest Community HealthcareArlington Heights, Illinois
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois BlueChoice Select
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
Coventry Health Care PPO Platinum
Coventry Missouri - HMO/POSFirst Choice
First Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Providence Health System Personal Option
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: